| Literature DB >> 29579186 |
Antonio Hernández-Madrid1, Thomas Paul2, Dominic Abrams3, Peter F Aziz4, Nico A Blom5,6, Jian Chen7, Massimo Chessa8, Nicolas Combes9, Nikolaos Dagres10, Gerhard Diller11, Sabine Ernst12, Alessandro Giamberti13, Joachim Hebe14, Jan Janousek15, Thomas Kriebel16, Jose Moltedo17, Javier Moreno1, Rafael Peinado18, Laurent Pison19, Eric Rosenthal20, Jonathan R Skinner21, Katja Zeppenfeld22.
Abstract
The population of patients with congenital heart disease (CHD) is continuously increasing with more and more patients reaching adulthood. A significant portion of these young adults will suffer from arrhythmias due to the underlying congenital heart defect itself or as a sequela of interventional or surgical treatment. The medical community will encounter an increasing challenge as even most of the individuals with complex congenital heart defects nowadays become young adults. Within the past 20 years, management of patients with arrhythmias has gained remarkable progress including pharmacological treatment, catheter ablation, and device therapy. Catheter ablation in patients with CHD has paralleled the advances of this technology in pediatric and adult patients with structurally normal hearts. Growing experience and introduction of new techniques like the 3D mapping systems into clinical practice have been particularly beneficial for this growing population of patients with abnormal cardiac anatomy and physiology. Finally, device therapies allowing maintanence of chronotropic competence and AV conduction, improving haemodynamics by cardiac resynchronization, and preventing sudden death are increasingly used. For pharmacological therapy, ablation procedures, and device therapy decision making requires a deep understanding of the individual pathological anatomy and physiology as well as detailed knowledge on natural history and long-term prognosis of our patients. Composing expert opinions from cardiology and paediatric cardiology as well as from non-invasive and invasive electrophysiology this position paper was designed to state the art in management of young individuals with congenital heart defects and arrhythmias.Entities:
Mesh:
Year: 2018 PMID: 29579186 DOI: 10.1093/europace/eux380
Source DB: PubMed Journal: Europace ISSN: 1099-5129 Impact factor: 5.214